Janux Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+3.95M	49.3%	$20.26	+$80M
Sells	3	-4.06M	50.7%	$53.99	-$219M
Net	+1	-117K	-1.5%		-$140M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jay Lichter	Director, 10%+ Owner	$397M	-$77.1M	-16.3%	Jun 26, 2024
Tighe Reardon	Acting Chief Financial Officer	$227M	-$40.1M	-15%	Jun 3, 2024
Avalon Ventures XI, L.P.	10%+ Owner	$162M	-$87.3M	-35.1%	Sep 6, 2024
Ra Capital Management, L.P.	Director, 10%+ Owner	$65.1M	+$65M	+47488%	Jun 26, 2024
Bregua Corp	10%+ Owner	$22M			Jun 15, 2021
Sheila Gujrathi	Director	$6.05M			Jun 26, 2024
Vickie L. Capps	Director	$3.73M			Jun 26, 2024
Orbimed Advisors Llc	Director	$1.36M			Dec 29, 2021
Thomas DiRaimondo	Chief Scientific Officer	$596K			Jan 2, 2024
Natasha Hernday	Director	$341K			Jul 19, 2024
Eric Dobmeier	Director	$341K			Jul 19, 2024
Jake Simson	Director	$137K			Jun 26, 2024
Alana B. McNulty	Director	$137K			Jun 26, 2024
Ronald W. Barrett	Director	$137K			Jun 26, 2024
Winston Kung	Director	$137K			Jun 26, 2024
David Alan Campbell	President and CEO, Director				Jan 2, 2024
Wayne Godfrey	Chief Medical Officer				Jan 3, 2023
Shahram Salek-Ardakani	Chief Scientific Officer				Jan 3, 2022
Byron Robinson	Chief Strategy Officer				Jan 2, 2024
Charles M. Winter	Chief Technical Officer				Jan 2, 2024
Maria Dobek	Vice President, Accounting				Aug 8, 2024
Stefan Heller	Director				Jun 14, 2022
Peter A. Thompson	Director				Jun 14, 2022
Andrew Hollman Meyer	Chief Business Officer				Jan 2, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.